Alzchem Group Ag · XETR:ACT
Alzchem — Q3 2021 Earnings Presentation
38 slides from Alzchem's earnings presentation, Nov 11, 2021
Slide 1: Agile Science Pure Results
AGILE SCIENCE PURE RESULTS
Slide 2: Alzchem Group presenters, November 11, 2021
group Vv ANDREAS NIEDERMAIER, CEO 3 DR. GEORG WEICHSELBAUMER, CSO 2021 November 11, 2021
Slide 3: Disclaimer
DISCLAIMER CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This presentation contains forward-looking statements about the business, financial condition and earnings performance of the AlzChem Group. These statements are based on assumptions and projections resting upon currently available info
Slide 4: Agenda — Analyst Presentation Q3 2021
AGENDA — ANALYST PRESENTATION Q3 2021 Executive Summary
Slide 5: Agile Science Pure Results
AGILE SCIENCE PURE RESULTS
Slide 6: Slide 6
Slide 7: iy
iy
Slide 8: Slide 8
Slide 9: Highlights
HIGHLIGHTS Sales and EBITDA at a historic high level in 9M/ puzchemon Despite raw material di] Sales and EBITDA Responsible care 5 shortages, AlzChem all-time high level prarcleonEminexges could ensure A ata /e hignieve a product for the Nor Forecast confirmed reduction of methane constant . and CO,
Slide 10: Dyhard
© Alzchem Group AG / Nov 2021 DYHARD Everyday, everywhere OVERVIEW DYHARDG@ is the brand name for high-performance thermoset epoxy cure systems based on Dicyandiamide hardeners, urone and imidazole accelerators & formulated epoxy resin systems PRODUCT FEATURES v Extraordinary long latency > convenie
Slide 11: Dyhard fluid system for hydrogen cylinders
© Alzchem Group AG / Nov 2021 DYHARD” mas v Dyhard® Fluid system for hydrogen cylinder in FuelCellElectricVehicles BENEFITS * Carbon fiber enforced pressure cylinder (> 700 bar) y * Approved in various type IV cylinder hydrogen applications »N MoTOR * Advantage over conventional systems: * Uninterru
Slide 12: Sales, EBITDA, Earnings per Share
Q3 Q3 2020 2021 AlzChem Group yoy % yoy % 2020 2021 1-9 1-9 SALES (in M€) 81.4 95.9 +17.9% 278.6 311.2 +11.7% EBITDA (in M€) 12.0 13.8 +15.4% 41.1 49.6 +20.5% EBITDA margin (in %) 14.7% 14.4% -0.3pp 14.8% 15.9% +1.2 pp Earnings per Share (in €) 0.37 0.46 +24.7% 1.46 2.14 +46.4% • SALES DELTA DELTA •
Slide 13: Agenda — Business and financial details
AGENDA — ANALYST PRESENTATION Q3 2021 ll. Business and financial details
Slide 14: Basics & Intermediates
nitRaLz? — Cher lka G CaD BASICS & INTERMEDIATES The "Basics & Intermediates" segment comprises the production of basic and intermediate products that are marketed as independent products for example in agriculture, steel production and the automotive sector and as raw materials for the manufacture
Slide 15: Basics & Intermediates segment
BASICS & INTERMEDIATES SEGMENT (in m€) Sales and EBITDA significantly above prior year SALES ANALYSIS Q3 Q4. QI Q2- Q3_ 4 QI 2 Q3 2019 2019 2020 2020 2020 2020 2021 2021 2021 Q3 Q4. QI Q2- Q3_ 4 QI 2 Q3 1-9 1-9 2019 2019 2020 2020 2020 2020 2021 2021 2021 2020 2021
Slide 16: Specialty Chemicals
< CREAMINO [D%rmex’ Bioselect? DYHARD Creapure SPECIALTY CHEMICALS The "Specialty Chemicals" segment produces and sells high-quality growth products in the area of specialty chemicals.
Slide 17: Specialty Chemicals segment
SPECIALTY CHEMICALS SEGMENT (in Mé€) Sales and EBITDA at a higher level than previous year SALES ANALYSIS Q3 Q4. QI Q2- Q3_ 4 QI 2 Q3 2019 2019 2020 2020 2020 2020 2021 2021 2021 Q3 Q4. QI Q2- Q3_ 4 QI 2 Q3 2019 2019 2020 2020 2020 2020 2021 2021 2021
Slide 18: Other & Holding
OTHER & HOLDING The "Other & Holding" segment offers infrastructure and energy supply services at our locations for the chemicals segments and for external customers. alzchem Vas group
Slide 19: Other & Holding segment
OTHER & HOLDING SEGMENT (in mé€) Service sales on previous year level Q3 Q4. QI Q2- Q3_ 4 QI 2 Q3 2019 2019 2020 2020 2020 2020 2021 2021 2021 <p, 04 0.5 Q3 Q4 Qi Q2 Q3 Q4 QI Q2. Q3 1-9 1-9 2019 2019 2020 2020 2020 2020 2021 2021 2021 2020 = 2021 1-9 2020 1-9 2021 SALES ANALYSIS
Slide 20: Balance Sheet
BALANCE SHEET (in Mé€) Increase of equity ratio Other non-current assets Deferred taxes for pension provision 27.2 67.4 Inventories Trade receivables EERE Other current assets 31.12.2020 30.09.2021 31.12.2020 30.09.2021 Equity Other non-current liabilities Pension provision Current liabilities
Slide 21: Cashflow
CASHFLOW (in m€) Strong investing activity in 1-9/2021 4 1-9 2021
Slide 22: Implementing Operating Targets
IMPLEMENTING OPERATING TARGETS Focus on key growth drivers, sustainability and pandemic management ) SUSTAINABILITY a= REALIZATION OF THE NEXT NITRALZ® CAPACITY EXPANSIONS STABLE FURTHER DEVELOPMENT OF PHARMACEUTICAL RAW MATERIALS EXPANSION OF PRODUCTION CAPACITIES (CREAPURE ®)/ ESTABLISH SALES OF L
Slide 23: Outlook 2021
Nov 2 zchem Group AC OUTLOOK 2021 (in me) Outlook from 06/2021 can be confirmed slightly significantly increasing to _to strongly Outlook from July 2021 can be confirmed increasing increasing . Assumptions ongoing recovery of economy significantly no further negative impacts from raw material supply
Slide 24: Financial Calendar
FINANCIAL CALENDER Upcoming dates NOV 11 NOV 22—24 DEC 7-8 FEB 24 APR 28 MAY 5 JUL 26 OCT 26 2021 2021 2021 2022 2022 2022 2022 2022 ey Quarterly Statement 3" Quarter 2021 Deutsches Eigenkapitalforum MKK — Minchner Kapitalmarkt Konferenz Annual Report 2021 Quarterly Statement 1+ Quarter 2022 Annual
Slide 25: Investor Relations
alzchem group Investor Relations T +49 8621 86-2888 F +49 8621 86-502888 ir@alzchem.com
Slide 26: Agenda — Appendix
AGENDA — ANALYST PRESENTATION Q3 2021
Slide 27: Alzchem Group balance sheet (in T€)
ALZCHEM GROUP (IN T€) 31.12.2020 30.09.2021 Deviation ALZCHEM GROUP (IN T€) 31.12.2020 30.09.2021 Deviation Intangible assets 1,810 1,754 -56 -3.1% Share capital 101,763 101,763 Tangible assets 175,062 176,882 1,819 1.0% RETAINED EARNINGS (+) / LOSS (-) 81,356 95,283 13,927 17.1% Investment properti
Slide 28: Pension Accounting (IFRS)
PENSION ACCOUNTING (IFRS) AlzChem Group (M€) 116,0 IN FINANCIAL PENSION SERVICE NET INTEREST STATEMENT PROVISION costs costs 31.12.2020 A FINAN RESULT BALANCE SHEET P&L CASHFLOW, Adjustment of market interest rate from 0.50 % Adjustment of expected pension trend from 1 Slowly increasing cash payment
Slide 29: Alzchem Group quarterly income statement (in T€)
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 ALZCHEM GROUP (IN T€) Deviation (Q3) Sep. 20 Sep. 21 Dev. YOY 2020 2020 2020 2020 2021 2021 2021 2021 Revenue 94.740 102.511 81.373 100.634 104.321 111.000 95.920 14.548 18% 278.624 311.242 32.618 32% Increase (+) / Decrease (-) in inventories of finished goods and 2.152 work
Slide 30: Alzchem Group income statement (in T€)
Q3 Q3 YTD YTD ALZCHEM GROUP (IN T€) Deviation (QoQ) Deviation (YoY) 2020 2021 Sep.2020 Sep.2021 Revenue 81,373 95,920 14,548 17.9% 278,624 311,242 32,618 11.7% Increase (+) / Decrease (-) in inventories of finished goods and work in progress 3,295 6,350 3,055 92.7% 2,286 2,586 300 13.1% Other income
Slide 31: Cashflow (in M€)
Q3 Q3 1-9 1-9 CASHFLOW (IN M€) 2020 2021 2020 2021 Consolidated earnings before taxes 5,347 7,340 21,554 31,303 Depreciation on fixed and intangible assets 5,668 6,207 16,992 17,877 Decrease in pension provisions -266 -325 -901 -1,075 Loss (+) / Profit (-) from the sale of non-current assets -2 -4 -
Slide 32: Sales and EBITDA by segment
2019 2020 2021 YTD Q3 2021 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Deviation PY (Q3) PY Actual Deviation PY (YOY) SALES T€ T€ T€ T€ T€ T€ T€ T€ T€ T€ T€ T€ T€ % T€ T€ T€ % Basics & Intermediates 35,465 37,844 41,693 34,405 36,012 38,266 32,320 39,837 41,070 45,178 42,465 10,145 24% 106,598 128,713 22,11
Slide 33: Executive Team
EXECUTIVE TEAM Alzchem Group AG os | ANDREAS NIEDERMAIER CEO WITH ALZCHEM SINCE 1999, AREAS OF RESPONSIBILITY Company Strategy, Finance & Controlling, Investor Relations & Communication, IT, Risk Management, HR, Supply Chain Management, Legal/Patents & Trademarks KLAUS ENGLMAIER coo WITH ALZCHEM SIN
Slide 34: Alzchem Group Locations
ALZCHEM GROUP LOCATIONS Production sites and sales companies @ SALES COMPANY SHANGHAI (CN) 4 ATLANTA (USA)
Slide 35: Fully Integrated Business Model (Verbund System)
FULLY INTEGRATED BUSINESS MODEL (“VERBUND” SYSTEM) ms O Segment Specialty Chemicals O cyan DIAMIDE cum Segment Basics & Intermediates BENEFITS OF “VERBUND” ¢ Full control of product quality and specifications * Lower costs * Higher financial predictability * Certainty of supply * Well positioned to
Slide 36: Our Products and Markets
hem Group AG / Nev 2021 OUR PRODUCTS AND MARKETS Successful with proven and new products in various industries MAIN PRODUCTS DESCRIPTION ey END-MARKETS CREAMINO A feed additive for broilers and pigs Feed additive 08 Creapure’ Premium brand for creatine monohydrate as a food supplement in sports nutr
Slide 37: Our Products and Markets
OUR PRODUCTS AND MARKETS Successful with proven and new products in various industries MAIN PRODUCTS DESCRIPTION END-MARKETS G Calcium carbide-based mixtures for hot metal desulphurization Steel industry Guanidine Salts Fuel for airbags, key production of the intermediate product Automotive Dicyandi
Slide 38: Key Share Data
© Alzchem Group AG / Nov 2021 KEY SHARE DATA Share Details as of November 9, 2021 10,176,335 SHARES OUTSTANDING eeu aa held LAST CLOSING PRICE EUR 22.10 MARKET CAPITALIZATION EUR 224.9 m TICKER ACT WKN A2YNT3 ISIN DEOOOA2YNT30 = ce Sec nn DESIGNATED SPONSOR Ouico Sevaloy Bank AG ey SHAREHOLDER STRUC